AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30608864 — intervention group
Group type: EXPERIMENTAL
Intervention: IKDC
Number of subjects: 298
Study 27695944 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical administration of 9 mg of sodium hyaluronate in 3 mL of a 0.9% sodium saline solution
Number of subjects: 103
Study 27695944 — intervention group
Group type: COMPARATOR
Intervention: Normal 0.9% sodium chloride saline solution
Number of subjects: 103
Study 24378515 — intervention group
Group type: EXPERIMENTAL
Intervention: Nighttime lower extremity splints
Number of subjects: 46
Study 24378515 — intervention group
Group type: COMPARATOR
Intervention: Liner only
Number of subjects: 46
Study 24378515 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (splint and liner)
Number of subjects: 46
Study 25204290 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive therapy based on traditional Chinese medicine (TCM) patterns including Bu‐Fei Jian‐Pi granules, Bu‐Fei Yi‐Shen granules, and Yi‐Qi Zi‐Shen granules along with conventional western medicine.
Number of subjects: 136
Study 25204290 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medicine (control group).
Number of subjects: 136
Study 21756153 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA + CBD ointment
Number of subjects: 60
Study 21756153 — intervention group
Group type: COMPARATOR
Intervention: CsA + emollient
Number of subjects: 60
Study 19617379 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 50 mg kg(‐1)
Number of subjects: 32
Study 18154123 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative bolus-assisted administration of 5-fluorouracyl
Number of subjects: 0
Study 15152108 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (education and aerobic exercise)
Number of subjects: 0
Study 15152108 — intervention group
Group type: COMPARATOR
Intervention: Relaxation intervention (education and relaxation)
Number of subjects: 0
Study 11295634 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoprevention trials
Number of subjects: 0
Study 9924299 — intervention group
Group type: EXPERIMENTAL
Intervention: Lodoxamide 0.1%
Number of subjects: 73
Study 9924299 — intervention group
Group type: COMPARATOR
Intervention: NAAGA 4.9%
Number of subjects: 73
Study 9924299 — intervention group
Group type: EXPERIMENTAL
Intervention: Lodoxamide 0.1% and NAAGA 4.9%
Number of subjects: 73
Study 7800739 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 mg nicotine cigarette
Number of subjects: 0
Study 7800739 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg nicotine cigarette
Number of subjects: 0
Study 7800739 — intervention group
Group type: COMPARATOR
Intervention: 0.1 mg nicotine cigarette (control)
Number of subjects: 0
Study 7800739 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (0.1 mg, 0.7 mg, 1.5 mg)
Number of subjects: 0
Study 7800739 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 mg and 1.5 mg groups
Number of subjects: 0
Study 3142197 — intervention group
Group type: EXPERIMENTAL
Intervention: CQP 201-403 (0.05 mg to 0.035 mg)
Number of subjects: 21
Study 3142197 — intervention group
Group type: EXPERIMENTAL
Intervention: CQP 201-403 (0.025 mg)
Number of subjects: 21
Study 3142197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 30977089 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromium and carnitine co-supplementation (200 μg/day chromium picolinate plus 1000 mg/day carnitine)
Number of subjects: 54
Study 30742692 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous endurance training (ET)
Number of subjects: 80
Study 30742692 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 80
Study 30742692 — intervention group
Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 80
Study 28535933 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir + Azithromycin (500 mg/day for 5 days)
Number of subjects: 50
Study 28535933 — intervention group
Group type: COMPARATOR
Intervention: Oseltamivir (Control)
Number of subjects: 50
Study 25496141 — intervention group
Group type: EXPERIMENTAL
Intervention: FTC/TDF
Number of subjects: 65
Study 25496141 — intervention group
Group type: COMPARATOR
Intervention: ZDV/3TC
Number of subjects: 65
Study 25496141 — intervention group
Group type: EXPERIMENTAL
Intervention: FTC/TDF (among subjects with lipoatrophy)
Number of subjects: 65
Study 25496141 — intervention group
Group type: COMPARATOR
Intervention: ZDV/3TC (among subjects with lipoatrophy)
Number of subjects: 65
Study 23899426 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress imagery
Number of subjects: 64
Study 23899426 — intervention group
Group type: COMPARATOR
Intervention: Neutral imagery
Number of subjects: 64
Study 21885896 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive Vibration Exercise (RVE)
Number of subjects: 24
Study 21885896 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive Exercise (RE)
Number of subjects: 24
Study 21885896 — intervention group
Group type: COMPARATOR
Intervention: No Exercise (Control)
Number of subjects: 24
Study 18341664 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retapamulin ointment 1% twice daily for 5 days
Number of subjects: 213
Study 18341664 — intervention group
Group type: COMPARATOR
Intervention: Topical placebo ointment
Number of subjects: 213
Study 18341664 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retapamulin ointment 1%
Number of subjects: 213
Study 16182424 — intervention group
Group type: EXPERIMENTAL
Intervention: Blurred images of living things
Number of subjects: 0
Study 16182424 — intervention group
Group type: COMPARATOR
Intervention: Blurred images of nonliving things
Number of subjects: 0
Study 16182424 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear images of living things
Number of subjects: 0
Study 16182424 — intervention group
Group type: COMPARATOR
Intervention: Clear images of nonliving things
Number of subjects: 0
Study 14499029 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturopathy
Number of subjects: 0
Study 14499029 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study 10949229 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound assessment at 32 weeks gestation
Number of subjects: 141
Study 10949229 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound assessment at both 28 and 32 weeks gestation
Number of subjects: 141
Study 8985529 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein energy malnutrition (measured by MUAC < 80%)
Number of subjects: 124
Study 8985529 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intake of beta-carotene-rich and vitamin A-containing foods
Number of subjects: 124
Study 8985529 — intervention group
Group type: EXPERIMENTAL
Intervention: General dietary improvement with increased consumption of dietary vitamin A
Number of subjects: 124
Study 1614990 — intervention group
Group type: EXPERIMENTAL
Intervention: WHT dietary intervention program
Number of subjects: 448
Study 1614990 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance at educational sessions
Number of subjects: 448
Study 1614990 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to the diet during the trial
Number of subjects: 448
Study 1614990 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline percentage of energy from dietary fat
Number of subjects: 448
Study 1614990 — intervention group
Group type: EXPERIMENTAL
Intervention: College education
Number of subjects: 448
Study 1614990 — intervention group
Group type: EXPERIMENTAL
Intervention: Feelings of deprivation
Number of subjects: 448
Study 1614990 — intervention group
Group type: EXPERIMENTAL
Intervention: Costliness of the diet in time and money
Number of subjects: 448
Study 1614990 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of a distaste for fat
Number of subjects: 448
Study 6730447 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbazol
Number of subjects: 61
Study 6730447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 6730447 — intervention group
Group type: COMPARATOR
Intervention: Biomet
Number of subjects: 61
Study 2874823 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 162,846 0.5 mg
Number of subjects: 10
Study 2874823 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 162,846 1.0 mg
Number of subjects: 10
Study 2874823 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 162,846 2.5 mg
Number of subjects: 10
Study 2874823 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 162,846 5.0 mg
Number of subjects: 10
Study 2874823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29483246 — intervention group
Group type: EXPERIMENTAL
Intervention: Restoration of vacant lots
Number of subjects: 445
Study 26878257 — intervention group
Group type: EXPERIMENTAL
Intervention: Error-based progression style during balance training
Number of subjects: 28
Study 26878257 — intervention group
Group type: COMPARATOR
Intervention: Repetition-based progression style during balance training
Number of subjects: 28
Study 24721143 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of motivational and volitional strategies to promote walking
Number of subjects: 582
Study 24721143 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 582
Study 23817284 — intervention group
Group type: EXPERIMENTAL
Intervention: Medplanner with care coordination
Number of subjects: 414
Study 23817284 — intervention group
Group type: EXPERIMENTAL
Intervention: MD.2 medication-dispensing machine with care coordination
Number of subjects: 414
Study 23817284 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 414
Study 20639023 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapy plus behavioral training (oxybutynin with pelvic floor muscle training and urge suppression techniques)
Number of subjects: 64
Study 20639023 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy alone (oxybutynin)
Number of subjects: 64
Study 20639023 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapy plus behavioral training
Number of subjects: 64
Study 20639023 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy alone
Number of subjects: 64
Study 18685512 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics and prebiotics treatment
Number of subjects: 0
Study 18685512 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study 16618656 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical decongestants (nafazoline and epinephrine)
Number of subjects: 0
Study 16618656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14583062 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronomodulated infusion of oxaliplatin, fluorouracil and folinic acid
Number of subjects: 0
Study 14583062 — intervention group
Group type: COMPARATOR
Intervention: Fixed-rate infusion of oxaliplatin, fluorouracil and folinic acid
Number of subjects: 0
Study 10770736 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-risk appraisal
Number of subjects: 400
Study 10770736 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive video
Number of subjects: 400
Study 10770736 — intervention group
Group type: COMPARATOR
Intervention: Standard clinic care alone
Number of subjects: 400
Study 10770736 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted situational behaviors
Number of subjects: 400
Study 8863366 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole plus amikacin (TMP/SMZ plus AMI)
Number of subjects: 217
Study 8863366 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 217
Study 1628634 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone
Number of subjects: 150
Study 1628634 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 150
Study 1628634 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone and Ketamine combinations
Number of subjects: 150
Study 6084124 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ), 50 mg twice daily
Number of subjects: 45
Study 6084124 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanabenz, 4 to 32 mg twice daily
Number of subjects: 45
Study 6084124 — intervention group
Group type: COMPARATOR
Intervention: Control (withdrawal of guanabenz)
Number of subjects: 45
Study 31451954 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric high-intensity cycling (ECC-H: 100% POmax)
Number of subjects: 10
Study 31451954 — intervention group
Group type: COMPARATOR
Intervention: Concentric moderate-intensity cycling (CONC-M: 50% POmax)
Number of subjects: 10
Study 31451954 — intervention group
Group type: COMPARATOR
Intervention: Eccentric moderate-intensity cycling (ECC-M: 50% POmax)
Number of subjects: 10
Study 31451954 — intervention group
Group type: EXPERIMENTAL
Intervention: All exercises (including ECC-H, ECC-M, and CONC-M)
Number of subjects: 10
Study 30065939 — intervention group
Group type: EXPERIMENTAL
Intervention: LH‐RHa therapy followed by a second orchidopexy
Number of subjects: 10
Study 30065939 — intervention group
Group type: COMPARATOR
Intervention: Surgery only (control)
Number of subjects: 10
Study 26176708 — intervention group
Group type: EXPERIMENTAL
Intervention: OLM/AML/HCTZ 40/10/25 mg
Number of subjects: 808
Study 26176708 — intervention group
Group type: EXPERIMENTAL
Intervention: OLM/AML/HCTZ 40/10/12.5 mg
Number of subjects: 808
Study 26176708 — intervention group
Group type: COMPARATOR
Intervention: OLM/AML 40/10 mg
Number of subjects: 808
Study 24810493 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1/carboplatin
Number of subjects: 229
Study 24810493 — intervention group
Group type: COMPARATOR
Intervention: paclitaxel/carboplatin
Number of subjects: 229
Study 23155342 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg daily for 8 weeks
Number of subjects: 193
Study 23155342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 20233513 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels within 48 h of admission in patients who died during hospitalization (n=5)
Number of subjects: 77
Study 20233513 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels within 48 h post-admission in patients who died within 6 months (n=9)
Number of subjects: 77
Study 18559039 — intervention group
Group type: EXPERIMENTAL
Intervention: Head down posture during showering
Number of subjects: 40
Study 18559039 — intervention group
Group type: COMPARATOR
Intervention: Head up posture during showering
Number of subjects: 40
Study 16022063 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive-behavioral therapy
Number of subjects: 60
Study 16022063 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychotherapy
Number of subjects: 60
Study 16022063 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 60
Study 11774064 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strength and endurance training
Number of subjects: 10
Study 11774064 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study 9519219 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebreathing method (RB) for TLCO measurement
Number of subjects: 35
Study 9519219 — intervention group
Group type: COMPARATOR
Intervention: Single-breath method (SB) for TLCO measurement
Number of subjects: 35
Study 8124481 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid infusion
Number of subjects: 14
Study 8124481 — intervention group
Group type: COMPARATOR
Intervention: Insulin (control)
Number of subjects: 14
Study 2642566 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG and VCN-modified autologous tumour cells (18 vaccinations over 2 years)
Number of subjects: 301
Study 2642566 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving immunotherapy)
Number of subjects: 301
Study 5649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalorphine
Number of subjects: 0
Study 5649 — intervention group
Group type: COMPARATOR
Intervention: Naloxone
Number of subjects: 0
Study 30958047 — intervention group
Group type: EXPERIMENTAL
Intervention: Wetsuit
Number of subjects: 33
Study 30958047 — intervention group
Group type: COMPARATOR
Intervention: Swimsuit
Number of subjects: 33
Study 30958047 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming Flume
Number of subjects: 33
Study 30261955 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-randomization lower extremity revascularization (LER)
Number of subjects: 13885
Study 30261955 — intervention group
Group type: COMPARATOR
Intervention: Surgical lower extremity revascularization
Number of subjects: 13885
Study 30261955 — intervention group
Group type: COMPARATOR
Intervention: Endovascular lower extremity revascularization
Number of subjects: 13885
Study 27374805 — intervention group
Group type: EXPERIMENTAL
Intervention: German Strengthening Families Programme 10-14 (SFP 10-14) consisting of seven sessions and four booster-sessions
Number of subjects: 292
Study 27374805 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention on parenting (Control)
Number of subjects: 292
Study 27374805 — intervention group
Group type: EXPERIMENTAL
Intervention: German Strengthening Families Programme 10-14 (SFP 10-14)
Number of subjects: 292
Study 24194580 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of social information
Number of subjects: 0
Study 24194580 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of individual with social information
Number of subjects: 0
Study 24194580 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulatory role of left inferior prefrontal cortex
Number of subjects: 0
Study 21464152 — intervention group
Group type: EXPERIMENTAL
Intervention: Facemask combined with Le Fort I osteotomy
Number of subjects: 32
Study 21464152 — intervention group
Group type: COMPARATOR
Intervention: Traditional rapid palatal expansion and FM therapy
Number of subjects: 32
Study 19619795 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical pulmonary vein isolation (SPVI)
Number of subjects: 60
Study 19619795 — intervention group
Group type: COMPARATOR
Intervention: Cox maze procedure
Number of subjects: 60
Study 17312278 — intervention group
Group type: EXPERIMENTAL
Intervention: Portal vein embolization (PVE) + CD133(+) bone marrow stem cell (BMSC) administration
Number of subjects: 13
Study 17312278 — intervention group
Group type: COMPARATOR
Intervention: Portal vein embolization (PVE) alone
Number of subjects: 13
Study 17312278 — intervention group
Group type: EXPERIMENTAL
Intervention: Portal vein embolization (PVE) + CD133(+) BMSC administration
Number of subjects: 13
Study 15126003 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise rehabilitation group (low-intensity exercise program for an average of 12.0+/‐2.4 days)
Number of subjects: 44
Study 15126003 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise advice)
Number of subjects: 44
Study 11641575 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemo-mechanical method (Carisolv system)
Number of subjects: 66
Study 11641575 — intervention group
Group type: COMPARATOR
Intervention: Mechanical method (conventional spoon excavators)
Number of subjects: 66
Study 8997547 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicergoline 30 mg b.i.d.
Number of subjects: 136
Study 8997547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 7967862 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (methronidazol and gentamicin, single preoperative dose)
Number of subjects: 141
Study 7967862 — intervention group
Group type: COMPARATOR
Intervention: Lavage of the surgical wound with physiologic serum
Number of subjects: 141
Study 7967862 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 141
Study 2442993 — intervention group
Group type: EXPERIMENTAL
Intervention: Indecainide (50 mg every 6 hours, increased to a maximum of 100 mg every 6 hours)
Number of subjects: 19
Study 2442993 — intervention group
Group type: COMPARATOR
Intervention: Quinidine (200 mg every 6 hours, increased to a maximum of 400 mg every 6 hours)
Number of subjects: 19
Study 31539601 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Stress Management Mobile Health application (CBSM mHealth) - 10 weekly modules
Number of subjects: 30
Study 31539601 — intervention group
Group type: COMPARATOR
Intervention: Generic healthy lifestyle app
Number of subjects: 30
Study 30352647 — intervention group
Group type: EXPERIMENTAL
Intervention: 4300 m at -10°C (HC)
Number of subjects: 10
Study 30352647 — intervention group
Group type: COMPARATOR
Intervention: thermo-neutral sea level (SL)
Number of subjects: 10
Study 27722772 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 64
Study 24047121 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPPV (unsynchronized nasal intermittent positive pressure ventilation)
Number of subjects: 67
Study 24047121 — intervention group
Group type: COMPARATOR
Intervention: NCPAP (nasal continuous positive airway pressure)
Number of subjects: 67
Study 24349392 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Intervention (AI)
Number of subjects: 20
Study 24349392 — intervention group
Group type: COMPARATOR
Intervention: Static Intervention (SI)
Number of subjects: 20
Study 20598983 — intervention group
Group type: EXPERIMENTAL
Intervention: Worsening renal function (WRF)
Number of subjects: 20063
Study 20598983 — intervention group
Group type: COMPARATOR
Intervention: No worsening renal function
Number of subjects: 20063
Study 18160192 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led brief motivational intervention
Number of subjects: 194
Study 18160192 — intervention group
Group type: COMPARATOR
Intervention: Leaflet about alcohol misuse
Number of subjects: 194
Study 17052633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan 30 mg
Number of subjects: 111
Study 17052633 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 25 mg
Number of subjects: 111
Study 17052633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 14602746 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (500 mg) and vitamin D (400 IU) supplementation twice daily for 1 year
Number of subjects: 192
Study 14602746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 14602746 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation
Number of subjects: 192
Study 10799375 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days of supplementation (1.67 MJ/d and 30 g protein/d)
Number of subjects: 17